[HTML][HTML] Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico

…, DM Duncanson, MA McArthur… - … England Journal of …, 2022 - Mass Medical Soc
Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

…, IJ Gordon, JH Cox, S Edupuganti, MA McArthur… - The Lancet, 2018 - thelancet.com
Background The Zika virus epidemic and associated congenital infections have prompted
rapid vaccine development. We assessed two new DNA vaccines expressing premembrane …

Dengue vaccines: recent developments, ongoing challenges and current candidates

MA McArthur, MB Sztein, R Edelman - Expert review of vaccines, 2013 - Taylor & Francis
Dengue is among the most prevalent and important arbovirus diseases of humans. To
effectively control this rapidly spreading disease, control of the vector mosquito and a safe and …

[HTML][HTML] Impact of Oral Typhoid Vaccination on the Human Gut Microbiota and Correlations with S. Typhi-Specific Immunological Responses

EA Eloe-Fadrosh, MA McArthur, AM Seekatz… - PloS one, 2013 - journals.plos.org
The resident microbial consortia of the human gastrointestinal tract play an integral role in
modulating immune responses both locally and systemically. However, detailed information …

[HTML][HTML] Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward

…, R Salerno-Goncalves, MA McArthur - Frontiers in …, 2014 - frontiersin.org
Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, and S.
Paratyphi A and B, causative agents of paratyphoid fever, are major public health threats …

[HTML][HTML] Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans

S Fresnay, MA McArthur, L Magder, TC Darton… - Journal of translational …, 2016 - Springer
Background Typhoid fever, caused by the human-restricted organism Salmonella Typhi (S.
Typhi), is a major public health problem worldwide. Development of novel vaccines remains …

[HTML][HTML] Heterogeneity of Multifunctional IL-17A Producing S. Typhi-Specific CD8+ T Cells in Volunteers following Ty21a Typhoid Immunization

MA McArthur, MB Sztein - PLoS One, 2012 - journals.plos.org
Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, continues
to cause significant morbidity and mortality world-wide. CD8+ T cells are an important …

The utility of human challenge studies in vaccine development: lessons learned from cholera

DAT Shirley, MA McArthur - Vaccine: development and therapy, 2011 - Taylor & Francis
Experiments in which virulent infectious organisms are administered to healthy adult volunteers
with the intent to deliberately induce infection have been practiced for centuries. Many …

[HTML][HTML] Activation of Salmonella Typhi-Specific Regulatory T Cells in Typhoid Disease in a Wild-Type S. Typhi Challenge Model

MA McArthur, S Fresnay, LS Magder, TC Darton… - PLoS …, 2015 - journals.plos.org
Salmonella Typhi (S. Typhi), the causative agent of typhoid fever, causes significant morbidity
and mortality worldwide. Currently available vaccines are moderately efficacious, and …

[HTML][HTML] Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells

Y Cong, MA McArthur, M Cohen… - PLoS neglected …, 2016 - journals.plos.org
Humans infected with yellow fever virus (YFV), a mosquito-borne flavivirus, can develop
illness ranging from a mild febrile disease to hemorrhagic fever and death. The 17D vaccine …